Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Nello Mainolfi, PhD$2.1B
Market Cap • 19/04/20242015
(há 9 anos)
NASDAQ
Listagem
Watertown
Sede • Massachusetts167
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
KYMRSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.